PolyPid (NASDAQ:PYPD) Raised to “Buy” at HC Wainwright
PolyPid (NASDAQ:PYPD – Get Free Report) was upgraded by research analysts at HC Wainwright to a “buy” rating in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The firm currently has a $11.00 target price on the stock. HC Wainwright’s price target would indicate a potential upside of 250.32% from […]
PolyPid (NASDAQ:PYPD – Get Free Report) was upgraded by research analysts at HC Wainwright to a “buy” rating in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The firm currently has a $11.00 target price on the stock. HC Wainwright’s price target would indicate a potential upside of 250.32% from […]
